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Introduction
The research enterprise is often charged
with responding to emerging scientific
needs and opportunities involving impor-
tant public health issues. The establish-
ment of the Vector Biology Network
(VBN) by The MacArthur Foundation to
address critical scientific, research, and
human resource needs in vector biology is
a model of how to respond to such a
charge efficiently and effectively. When
the Network was formed in 1989, the
resurgence of vector-borne diseases, in-
cluding malaria and dengue, had revealed
critical research and training needs in
vector biology. Major knowledge gaps in
vector molecular biology and pathogen
transmission limited development of new
approaches for vector and disease control.
The loss of vector biologists/medical
entomologists complicated control of these
diseases. Members of the VBN, an inter-
national consortium of research laborato-
ries, collaborated in the development and
application of modern molecular and
genetic approaches in vector biology and
in the training of a new cadre of scientists
capable of developing and applying mod-
ern tools to combat these diseases. The
VBN exploited the expertise and resources
of the consortium institutions, and exceed-
ed all of its milestones, including: devel-
opment of molecular and genomic ap-
proaches in vector biology; genetic
transformation of insect vectors; charac-
terization of vector immune systems;
identification of molecular and biological
bases of vector competence; and exploita-
tion of identified vulnerabilities to interfere
with pathogen transmission. The VBN
recruited many established scientists from
other fields and trained a new generation
of leaders in vector biology. Most impor-
tantly, the VBN participated in and helped
catalyze a remarkable renaissance in
vector biology/medical entomology.
A Case Study of Collaborative
Development of a Research
Field
Research on mosquitoes and other
arthropod vectors of infectious diseases is
of great importance for tackling neglected
tropical diseases in the developing world.
Vector biology is now a well-established
and rapidly advancing field that is provid-
ing new understanding of vectors and
vector pathogen interactions and creating
new opportunities for vector-borne disease
(VBD) control. Many key milestones and
recruitment and training of new research-
ers in this field were made possible by the
coalescence of several laboratories in the
US and Europe into a collaborative
research network focused on the biology
of disease vectors. The Vector Biology
Network (VBN) was established and fund-
ed for ten years (1990–2000) by The John
D. and Catherine T. MacArthur Founda-
tion. The VBN was reinforced through
endorsement and, in some cases, coordi-
nated funding by the World Health
Organization (WHO) and national re-
search agencies and foundations, which
collectively contributed to a remarkable
renaissance of vector biology. The history
of the VBN provides a valuable case study
of how effective strategies can be devel-
oped and deployed to address cost-effec-
tively newly recognized scientific challeng-
es related to important public health and
social goals.
The Challenge: Resurgence of
Vector-Borne Diseases
The stimulus for developing the VBN
was the worldwide resurgence of VBDs.
While extraordinary advances in antibiot-
ics and vaccines have controlled many
infectious diseases, VBDs continue to
afflict hundreds of millions of humans
annually, resulting in inestimable morbid-
ity and misery and millions of deaths in
disease-endemic countries [1]. These dis-
eases are resurging in areas where they
were previously controlled and are newly
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gence is associated with multiple causes,
including: biological factors such as the lack
of efficacious vaccines and therapeutics,
development of drug resistance in patho-
gens and pesticide resistance in arthropod
vectors, and limitations on pesticide usage
because of safety and environmental
concerns; infrastructural factors such as the
deterioration of public health systems for
VBD surveillance and control, and attri-
tion of scientists and public health practi-
tioners trained in medical entomology or
tropical medicine; and demographic and social
factors such as rapid population growth,
rampant unplanned urbanization in the
tropics, and human migration into unde-
veloped areas containing new pathogens
and reservoir hosts for known pathogens.
Because of these factors, the prognosis for
the control of VBDs was bleak. New targets
and approaches for control were critical,
and major knowledge gapsinvector biology
needed to be addressed in order to increase
the armamentarium for disease control.
Opportunities and Roadblocks:
The Need To Infuse Genetics,
Molecular Biology, and
Technology into Vector Biology
Bytheearly 1980s, majorconceptualand
technologicaladvancesinmolecularbiology
and genetics were reshaping biomedical
research. The manipulation of DNA with
recombinant techniques revolutionized the
study of gene expression, development,
evolution, and population biology. Genetic
transformation of Drosophila emerged as a
powerful approach to gene identification
and characterization in a model arthropod
[2]. Rapid progress in the development of
inexpensive, widely applicable techniques
for gene sequencing fostered genome-wide
rather than gene-by-gene approaches in
biomedicine. This explosion of molecular
technology and knowledge created unpar-
alleled opportunities for rapid advances
even in neglected fields; indeed, new
molecular studies of pathogens revealed
exciting opportunities for development of
diagnostics, drugs, and vaccines. However,
the study of insect vectors of human disease
progressed more slowly for several reasons:
(i) the relatively small number of scientists
working in the area; (ii) the strong focus of
medical entomologists on fieldwork rather
than on basic laboratory research; (iii) the
historical dissociation in American acade-
mia of medical entomology (in schools of
agriculture) and parasitology (in schools of
medicine), which hindered integration of
knowledge on the interaction of parasites
with both their human and insect hosts; and
(iv) the assumption that new more effective
anti-parasite drugs and vaccines were
imminent.
The smallsizeand difficulty of laboratory
maintenance of many vectors complicated
their study through existing approaches and
tools. For good reasons, most insect scien-
tists focused on the biochemistry and
physiology of more tractable non-vector
model species. The genetics of D. melanoga-
ster and the physical size of moths (especially
Bombyx, Cecropia,a n dManduca) made them
attractive model systems. In contrast, vec-
tors were inconvenient to maintain, genetic
information was lacking, and biochemical
approachesweredaunting;therefore,vector
species were largely neglected. This resulted
in major knowledge gaps, and vectors were
depicted as ‘‘black boxes’’ in natural
pathogen transmission cycles. Vector com-
petence and vectorial capacity were opera-
tionally rather than mechanistically defined.
There was a clear need for the application
of modern molecular technology for illumi-
nating the black box of the vector and for
training a new generation of vector biolo-
gists well-versed in modern technology.
Early applications of simple molecular
tools to VBDs allowed identification of
cryptic vector species, detection of insecti-
cideresistance,andfacilitatedtheanalysisof
disease epidemiology and the targeting of
interventions. The remarkable taxonomic
and population analyses of African mosqui-
toes of the Anopheles gambiae complex by
Mario Coluzzi and colleagues [3] were
pioneering applications to vectors of tools
developed for chromosome mapping in
Drosophila. Molecular tools contributed to
the elucidation of species complexes [4], the
genetics and biochemistry of insecticide
resistance [5], and basic functions such as
reproduction and vitellogenesis in mosqui-
toes [6]. These early studies provided a
powerful paradigm that encouraged devel-
opment of molecular and genetic tools for
vectors. The VBN was formed to explore
such tools toward identifying new targets
and approaches for surveillance, preven-
tion, and control of vectors and VBDs.
Roots of The MacArthur
Foundation Vector Biology
Network
The John D. and Catherine T. Ma-
cArthur Foundation was established in the
late 1970s. Reflecting their personal inter-
ests, perspectives on societal needs, and
the Foundation’s location in Chicago, the
Foundation’s new Board of Directors
selected mental health and urban issues
for emphasis, and established the Ma-
cArthur Fellows Program to recognize and
reward extraordinary creative potential in
individuals.
When Dr. Jonas Salk joined the Board
in the early 1980s, he began a series of
meetings with health experts to identify
areas of special need and opportunity for
the new Foundation. A momentous meet-
ing was held with Dr. Kenneth Warren,
then the Director of the Rockefeller
Foundation’s Program on the Great Ne-
glected Diseases of Mankind, an interna-
tional network of research units collabo-
rating on the diseases of poor countries
with a focus on malaria. Dr. Warren,
confident that the time was right for a
major effort to understand these diseases
at the molecular level, convinced Dr. Salk
that this was a significant opportunity for a
new foundation. Dr. Salk, in turn, per-
suaded the Foundation’s Board.
Parasite Biology Consortium
After a year of preparation by Founda-
tion staff, The MacArthur Foundation
established in 1984 a five-year program
of research and supporting activities to
reduce the global burden of illness due to
parasitic diseases. This commitment was
based on the conviction that application of
modern molecular and cellular biology,
genetics, and immunology would greatly
accelerate progress in understanding and
combating these diseases. The Foundation
decided to pursue this ambitious goal
through a relatively novel approach.
Rather than supporting individual re-
searchers through separate, discrete
grants, it funded an international group
of laboratories—the Consortium on the
Biology of Parasitic Diseases (Parasite
Biology Consortium)—committed to col-
laborating on applying the latest biological
techniques to research on the molecular
biology of parasites. (The Parasite Biology
Consortium Laboratories were at Case
Western Reserve University, Columbia
University, Harvard University, Johns
Hopkins University, National Polytechnic
Institute (Mexico City), New York Uni-
versity, Stanford University, University of
California Berkeley, Walter and Eliza Hall
Institute (Melbourne, Australia), the Weiz-
mann Institute of Science (Revohot, Isra-
el), and Yale University.) The Foundation
also supported efforts that would comple-
ment the Consortium, including: the
WHO Special Programme for Research
and Training in Tropical Diseases (WHO-
TDR); the Marine Biological Laboratory’s
Summer Course on Molecular Parasite
Biology at Woods Hole; a program of
small workshops and conferences; and
discretionary and technical support grants
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advance the field of parasite biology.
The Formation of the Vector Biology
Consortium
When the Parasite Biology Consortium
was established, vector biology was even
further behind than parasite biology in the
application of modern techniques. Three
Consortium laboratories (based at Case
Western Reserve, Harvard, and Yale Uni-
versities) had research groups working on
the biology of parasite vectors, but, at least
initially, the importance of such studies was
not recognized by the Foundation. Howev-
er, by the mid 1980s, it was becoming
evident that the effective control of parasitic
diseases in tropical endemic areas would
require a multifaceted strategy aimed at
both preventing and treating parasitic
infections and controlling their transmission
by insects. Moreover, there was a growing
sense at the Foundation that vector biology
was a field ripe for rejuvenation based on
the introduction of the molecular and
genetic methods that were revolutionizing
the study of parasites.
This perspective led the MacArthur
Foundation in 1985 to convene a small,
one-day meeting of scientists to explore
how the Foundation might promote this
development. Participants included: B.
Beaty (Colorado State University (CSU)),
M. Coluzzi (University of Rome), F.
Kafatos (Harvard University, and IMBB,
Crete), T. Mahowald (Case Western
Reserve University (CWRU)), L. Miller
(National Institutes of Health (NIH)), L.
Riddiford (University of Washington), and
D. Prager, the Foundation Program Offi-
cer. The consensus of the meeting partic-
ipants was that the time was right for a
major research effort directed toward:
understanding, at the molecular and
genetic levels, the properties of insect
vectors that foster parasite infection and
transmission; and developing mechanisms
for interfering with these processes.
Establishment of and Mandate
for the Vector Biology Network
Over the next two years, the ideas from
that meeting germinated, and led the
Foundation to create a new research
network focused on vector molecular
biology to complement the Parasite Biol-
ogy Consortium. The Vector Biology
Network would include vector laboratories
within the Parasite Biology Consortium,
and would also exploit newly emerged
opportunities. These included the com-
mitment of F. Kafatos to devote 50% of
his laboratory to vector biology; the
opportunity for A. James, then at Harvard,
to start a new vector research program at
the University of California Irvine; the
convergence of pertinent expertise, infra-
structure, and capacity at the NSF-funded
Center for Insect Sciences at the Univer-
sity of Arizona; and the establishment of
the Arthropod-borne and Infectious Dis-
eases Laboratory at CSU. The VBN
laboratories and respective program lead-
ers (PLs) were CWRU (A. Mahowald and
M. Jacobs-Lorena), Yale (R. Tesh), Har-
vard and Crete (F. Kafatos), CSU (B.
Beaty), University of Arizona (J. Hildeb-
rand), University of California Irvine (A.
James), and NIH (L. Miller). A VBN
consortium laboratory was subsequently
established at the Centers for Disease
Control–Division of Parasitic Diseases,
which later moved to the University of
Notre Dame (F. Collins).
The VBN was proposed formally to the
MacArthur Foundation Board at the time
of the renewal of the Parasite Biology
Consortium (December 1989) and re-
ceived unanimous approval. The Founda-
tion specified a clear mandate: 1) estab-
lishing and legitimizing a credible field of
parasite vector molecular biology with
strong intellectual and methodological
foundations; 2) attracting to the field
established biologists familiar with the
latest advances in molecular and cellular
biology and genetics; 3) training future
generations of parasite vector biologists.
Development of Specific Goals and
Strategy: The First Meeting of the
Program Leaders (PLs)
This critical meeting of the VBN PLs
was held at The MacArthur Foundation in
Chicago on November 20–21, 1989. The
intent of the meeting was to reach
consensus on long-range goals, initial
priorities, strategies for mobilizing intel-
lectual, scientific, and technical resources;
and on defining major activities and
responsibilities of the PLs. It was agreed
that progress in understanding and con-
trolling disease transmission by insect
vectors would require an understanding
of the relationship between molecular and
behavioral events, and close integration of
the new discipline into the larger fields of
tropical medicine, medical entomology,
epidemiology, and ecology. The challenge
was to bridge the whole spectrum of
inquiry from the molecular to the ecolog-
ical. The overarching goal for the VBN
was to infuse modern molecular biological
and genetic techniques into vector biology.
Research prioritiesand goals for the VBN
that emerged from this meeting included: a)
development and exploitation of genomic
approaches in vector biology; b) develop-
ment of techniques for genetic transforma-
tion of insect vectors; c) characterization of
the immune system of vectors; d) determi-
nation of the molecular and biological bases
of vector competence and vectorial capacity;
e) exploitation of identified vulnerabilities to
develop effective strategies for interfering
with pathogen transmission.
An equally critical outcome of this
meeting was the emergence, from the
beginning, of an interactive and cohesive
VBN spirit based on shared vision, goals,
and philosophy. This rapport led to a
coherent and systematic plan for accelerat-
ing the development of a new field, vector
molecular biology. The adopted strategic
elements included: a) regular PL meetings,
two to three per year, plus broader Network
meetings; b) collaborative research pro-
grams targeting major scientific goals; c)
involvement of established scientists from
other fields conversant with modern molec-
ular biological and genetic techniques; d)
training both within Network laboratories
and in a formal course; e) an efficient
administrative structure to facilitate
achievement of Network goals.
The collaborative research approach
was critical to the success of the Network.
It exploited the separate and combined
expertise of the Network laboratories in a
way that maximized flexibility in achieving
Network goals.
Network Meetings: Sustaining the
Network and the Field
The collaborative spirit of the first
meeting of the PLs was continued in the
subsequent meetings and diffused into the
Network as a whole. The ethos was
sharing, before publication, of all data,
research achievements, experimental
models, biological materials, and draft
manuscripts; use of research facilities;
and visits or exchanges among Network
laboratories. In addition, strategic meet-
ings and shared training programs were
designed to tackle roadblocks and address
opportunities for moving the field forward
to stimulate vector biology research, and
to accelerate application of new informa-
tion on the control of parasite transmission
in tropical endemic areas.
The PL and other meetings were critical
for solidifying the program’s cohesion and
effective operation. Small (30–40 partici-
pants) and intensive (2–3 day) workshops
proved to be an efficient mechanism for
developing effective strategies to overcome
specific technical barriers to progress in the
field. They included network and non-
network experts with pertinent experience
in the topic of interest, and were designed to
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one addressed a specific topic: genofmics,
transformation, or bioinformatics. Network-
wide institutes were devoted principally to
VBN participants with one or two plenary
speakers from outside the Network; they
focused on VBN scientific issues and
promoted networking and collaboration
among Network scientists.
Engaging the Broader Community:
Key Partnerships
Key to the success of the new enterprise
was inclusiveness: the early and sustained
involvement of other leaders and propo-
nents of vector biology from multiple
institutions and agencies. Particularly
noteworthy were joint planning and coor-
dinated funding activities with: (i) the
National Institutes of Health (NIH)
through Drs. S. James and K. Aultman
(Program Officers for vector biology and
related fields at the National Institute of
Allergy and Infectious Diseases [NIAID]);
(ii) WHO-TDR through two successive
Directors, Drs. T. Godal and C. Morel,
and Dr. B. Dobrokhotov, manager of the
Biology and Control of Vectors program
at TDR; and (iii) foundations such as the
Wellcome Trust and the Howard Hughes
Medical Institute. These collaborations
played a large role in promoting the field
and developing the personnel and tools
needed to address the problems.
The Tucson Meeting and Its Impact
A major goal of the VBN was the
genetic manipulation of vectors to block
their ability to transmit pathogens. A
seminal meeting entitled ‘‘Prospects for
Malaria Control by Genetic Manipulation
of its Vectors’’ was held January 27–31,
1991, in Tucson, Arizona, and was
sponsored by The MacArthur Foundation,
WHO-TDR, and the University of Ar-
izona. Participants included scientists with
expertise in basic molecular biology,
genetics, epidemiology, entomology, vec-
tor control, and public health (Figure S1).
By the end of the meeting, a consensus
had emerged that the use of molecular
approaches to vector and disease control
should be pursued as a real possibility and
not as an impossible dream. The official
report of the meeting was published by
WHO-TDR (TDR/BCV/MAL-ENT/
91). On this basis, TDR established a 20-
year plan for the development of malaria
refractory mosquitoes. The first projects of
the plan focused on genome mapping,
identification of selectable markers, and
transposable elements, and on database
construction.
The TDR’s 20-year plan was accelerat-
ed as DNA methods became increasingly
powerful and less expensive, and manipu-
lating and sequencing mosquito genomes
became feasible.
The ability to coordinate research
efforts through the VBN resulted in the
achievement of a key milestone of the
TDR plan—transgenic mosquitoes. A PL
meeting at the Biology of Disease Vectors
(BDV) course in Crete in 1994 resulted in
a VBN plan to develop transgenesis as a
tool in vector biology. Transformation of
the vector of dengue fever, Aedes aegypti,
was published in 1998 by the group of A.
James, in collaboration with F. Collins
[7,8], and of the malaria vectors An.
stephensi [9] by the teams of A. Crisanti,
F. Kafatos, and C. Savakis, and An. gambiae
[10] by M. Benedict and colleagues.
VBN workshops on genomics and vector
parasite interactions led to the mapping of
pathogen refractory genes, and a VBN
institute led to the initiation of genomics
and informational Web sites for An. gambiae
and Ae. aegypti. Finally, initial discussions
between L. Miller, F. Collins, and F.
Kafatos at the BDV course in Bamako,
Mali (1997), led to draft VBN plans for fully
sequencing Anopheles gambiae and to the first
Anopheles Genome Meeting, which was
organized by TDRand the VBN in Geneva
[11] to discuss potential strategies. Indepen-
dent sequencing plans were developed by
Genoscope and P. Brey at Institut Pasteur.
The first An. gambiae expressed-sequence tag
(EST) sequencing project was co-funded in
2000 by the VBN, NIH-NIAID, and
WHO-TDR. An An. gambiae Genome
Summit was convened in March 2001 in
Paris by TDR and Institut Pasteur. One
and a half years later, the full genome
sequence was completed at Celera Geno-
mics and at Genoscope, with funding from
NIAID and the French Ministry of Re-
search, respectively, and was authored by
the An. gambiae Consortium [12].
Vector Biology Network
Funding, Activities, and Impact
The VBN was supported by relatively
modest funding from The MacArthur
Foundation (USD 1.2 million total annually
for eight laboratories over ten years) to
catalyze and promote the field of molecular
vector biology. Yet the impact on vector
biology was extraordinary. Metrics of
success in this goal include: recruitment of
established scientists into the field, research
productivity of VBN and its collaborators,
training of new vector biologists, vector
biology publications in high-quality jour-
nals, external funding (largely by NIH-
NIAID), and vector biology presentations
and sessions at the Annual Meeting of The
American SocietyofTropicalMedicine and
Hygiene (ASTMH).
Recruitment of New Scientists into
the Field of Vector Molecular
Biology
The Network recruited and eventually
co-opted outstanding, nationally and in-
ternationally recognized scientists of other
specialties into the field of vector biology.
In many cases, the respective VBN teams
were gradually transformed from a focus
on Lepidoptera and Drosophila research or
virology research into leading vector
research laboratories. Numerous young
scientists were recruited into the field as
postdoctoral fellows or junior faculty
associated with the network research




were made by the laboratories of the VBN
and their collaborators, consistent with the
research priorities and goals set by the
Network. Beyond the milestones of culi-
cine and anopheline transformation and
genomic analysis, major advances in
vector gene manipulation, molecular char-
acterization, and functional analysis result-
ed from research activities of the VBN
groups, their collaborators, and many
other laboratories. These included: the
use of microsatellites to establish a genetic
map (e.g., [13]); BAC cloning and in situ
hybridization of chromosomes; cloning
microdissected chromosome regions (e.g.,
[14]); use of molecular markers to charac-
terize vector chromosomes and genomes,
and to identify cryptic species [15–19];
development and use of robust tools and
approaches to follow gene flow within and
between species (e.g., [20–26]); exciting
new information concerning the molecular
biology of vector immunity (e.g., [27]),
olfaction and host-seeking (e.g., [28]),
salivary gland biology (e.g., [29,30]), and
blood meal digestion and interactions with
pathogens (e.g., [31–36]); introduction of
virus-based transducing systems for gene
expression and characterization in vectors
(e.g., [37–39]); and the proof of concept
that molecular intervention can lead to the
disruption of pathogen transmission by
vectors [40–42]. These goals were attained
in just over ten years and, together with
important achievements of other col-
leagues in this expanding field, firmly
reestablished vector biology as a dynamic
field.
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immune system [27] is an excellent
example of how VBN effort supported
the development of a vibrant new field. A
VBN WHO-supported pilot EST/cDNA
cloning and sequencing project [43] ac-
celerated the process, and VBN scientists
leveraged resources and initiated new
collaborations in vector immunity. Com-
parative biology approaches and transfer
of information from D. melanogaster allowed
innate immunity studies in An. gambiae to
progress well, even prior to genome
sequencing. With the publication of the
An. gambiae genome, research in vector
immunity exploded for both anopheline
and culicine mosquitoes (e.g., [44–46]).
The new tools and information developed
during these exciting years led directly to
landmark demonstrations by VBN labo-
ratories of: the role of insect innate
immunity in vector competence (e.g.,
[47,48]), new robust RNA interference
methods for gene function analysis in
vectors (e.g., [47]), the RNAi response as
a robust immune response to arboviruses
in vectors (e.g., [49]), and the molecular
manipulation of vectors to make them
resistant to dengue and malaria transmis-
sion (e.g., [50,51]). The recent publication
of the Ae. aegypti genome [52] and multiple
other vector genome projects in progress
undoubtedly will contribute to the pro-
ductivity of the field. The establishment by
the NIH of VectorBase [53] to coordinate
and promulgate molecular information on
vectors is testimony to the explosion of
information, knowledge, tools, laborato-
ries, and investigators in vector biology.
VBN Training
Training was an integral part of the
VBN strategic plan from the beginning.
Much of the training of postdoctoral
fellows, graduate students, and faculty
occurred in the respective VBN research
laboratories. Important additional training
activities included Network development
of the BDV course, publication of corre-
sponding textbooks, and VBN faculty
participation in WHO-TDR regional
training activities in population genetics
and bioinformatics.
Development of the BDV course was
one of the first decisions of the Network
PLs and was inaugurated in 1990. The
VBN members at Colorado Sate Univer-
sity hosted the first several years, and in
1994 it rotated to overseas venues to
broaden participation and facilitate the
inclusion of scientists and students from
disease-endemic countries. Host countries
included: Greece (Institute of Molecular
Biology and Biotechnology in Crete), Mali
(Faculty of Medicine, Pharmacy and
Odonto-Stomatology), Brazil (Foundation
at the Institute of Oswaldo Cruz), Czech
Republic (University of Southern Bohemia
and Institute of Parasitology), Mexico
(Institute Nacional de Salud Publica),
Thailand (Mahidol University), and the
United Kingdom (Liverpool School of
Tropical Medicine).
This intensive two-week course, a total
immersion in vector biology, provided a
common background and conceptual
framework for a new generation of
researchers, who could apply modern
approaches to the study and control of
disease vectors. It also was invaluable for
networking among students, and between
students and faculty experts. The course
was aimed both at scientists newly recruit-
ed into the field from diverse areas and for
those with more conventional training in
VBDs. Advanced graduate students, post-
doctoral fellows, and independent investi-
gators were introduced to the biology of
disease vectors, with emphasis on current
molecular approaches. A mini-symposium
was held each year and emphasized a
topic of importance to vector biology.
These topics included the biology of
vector–parasite interactions, Ae. aegypti
and An. gambiae biology and control,
pesticide resistance and stewardship, ad-
vances in vector molecular biology and
tools, and bioinformatics and genomics.
Each year, approximately 35 students and
25 faculty participated in the course.
Faculty members were scientists from the
VBN, other universities, government insti-
tutions, and biotechnology companies
from around the world. Every year 16 or
more nations were represented. Small
class size and the selection of renowned
scientists for faculty provided an unparal-
leled learning and networking experience.
Admission was very competitive. To date,
558 students from 67 countries and 154
faculty from 21 countries have participat-
ed in the course. The course was consid-
ered by WHO-TDR to be one of its
flagship training programs.
The first course was restricted to VBN
laboratories as a means of testing the
curriculum and of promoting interaction
among Network participants. All of the
PLs, key research personnel, and postdoc-
toral fellows were in attendance, creating a
coherent and unified learning framework
that promoted Network evolution and
maturation. This contributed to a com-
mon vision for the expanding Network,
and resulted in a true community of
scientists working toward common goals.
Subsequent courses were sponsored prin-
cipally by The MacArthur Foundation
and WHO-TDR, but also received sup-
port from the Howard Hughes Medical
Institute and the NIH, permitting financial
assistance to students and faculty from
developing countries. Many students and
faculty described the course as a career-
and life-changing experience. Further-
more, students from the early years have
emerged as leaders in the field and as
faculty in the course. Most of the new
vector biology positions in academia and
government in the US in recent years have
been filled by former BDV course partic-
ipants.
After the course had been offered for
several years, it became clear that the
syllabus provided the basis for a textbook
on vector biology with emphasis on
modern molecular and quantitative ap-
proaches. The textbook The Biology of
Disease Vectors [54] was published by the
University Press of Colorado in 1996 and
was provided free of charge to students
and faculty in the course and to institu-
tions in disease-endemic countries. An
updated edition of The Biology of Disease
Vectors [55] was published by Elsevier in
2005.
Network Participation in Building a
Scientific Community
Network members became key contrib-
utors in the development of vector biology
as a field. Network members: (i) organized
WHO-TDR workshops throughout the
world on vector population genetics and
molecular taxonomy, vector bioinfor-
matics, and vector control; (ii) were central
to the emergence of vector genome
projects; (iii) contributed to the develop-
ment of the Keystone Symposium ‘‘To-
ward the Genetic Modification of Arthro-
pods,’’ which became an important
meeting for vector and arthropod biolo-
gists; (iv) established the ‘‘Molecular and
Population Biology of Mosquitoes and
Other Vectors’’ workshop held biannually
in Crete, which has become a key meeting
for vector biologists; (v) organized sessions
in ASTMH meetings, Gordon Conferenc-
es, and specialty meetings; (vi) participated
in the BDV courses; and (vii) trained
innumerable visiting scientists, postdoctor-
al fellows, and students in new tools and
techniques in their respective laboratories.
The Renaissance of Vector Biology
The overarching goal of the VBN was
to catalyze the development of the vector
biology field in the era of molecular
biology. A number of specific metrics of
success are evident following analysis of
time periods before and after the forma-
tion of the VBN. An impressive and
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publications in leading journals (Figure 1).
Prior to 1990, typically fewer than 20
vector biology papers appeared in these
journals, but a tenfold increase in the
number of publications began in 1991,
and has now reached 150 to 200 publica-
tions per year in these journals alone. This
increase reflects the recruitment of new
scientists to the field, the quality of their
science, and the development of new tools
and approaches to investigate vectors.
Concomitant with the increase in publica-
tions, a substantial increase is observed in
the number of vector biology grants at the
US National Institutes of Health (Figure 2),
principally the NIAID. Most of this
increase is in mosquito-related grants,
reflecting in part the influence of the An.
gambiae genome project. The portfolio of
vector biology grants grew from approxi-
mately 50 to .120 in the years of the
VBN (1990–2000). While the overall NIH-
NIAID budget doubled during this period,
increases in vector-related studies out-
paced this increase. Furthermore, the
portfolio continued to increase during the
reporting period, reflecting the firm estab-
lishment of the new discipline. This latter
achievement is emphasized with the for-
mation of a new dedicated NIH study
section in Vector Biology. The NIH
intramural program also increased, with
vector biology research equalling malaria
research for the first time. The final
indicator of the development of vector
biology is the number of scientific presen-
tations and sessions at the annual meeting
of a relevant and representative scientific
society, The American Society of Tropical
Medicine and Hygiene. Review of the
annual meeting programs from 1990 to
2005 show that vector biology sessions and
presentations increased over the years,
from typically fewer than 50 in the early
1990s to more than 200 in 2005 (Figure 3).
The addition of new journals with em-
phases in vector biology, e.g., Insect
Molecular Biology, Vector-Borne and Zoonotic
Diseases, Journal of Insect Sciences, also is
testimony to the resurgence of vector
biology.
The Network laboratories contributed to
a surge in these metrics but, importantly,
the increases reflect the emergence of a
widespread, robust new field involving
many institutions, programs, and principal
investigatorsinbothdevelopedanddisease-
endemic countries. Although the limited
funding for the VBN inevitably disappoint-
ed some early practitioners who could not
be included in the program, ultimately
everyone benefited from the robust devel-
opment of the field and its funding.
Lessons Learned—The Funder’s
Perspective
Collaborative research networks were a
relatively new phenomenon when the
VBN was established in 1989, and repre-
sented an experiment in organizing sci-
ence to tackle some of society’s most
significant challenges. For that reason, it
is helpful to reflect on the work of the
VBN, on how it was structured, and on
how it operated. The following thirteen
areas represent key lessons from the
VBN’s experience.
Network Concept
The research network is a complement
to, not a replacement for, individual
research supported by traditional funding
sources. It is designed to add value to
individual scientific pursuits by providing a
setting in which the talents of individuals
can be mobilized in a reinforced manner
to address scientific issues of common
concern: by conducting a kind of research
that would not otherwise be possible, and
by bringing diverse research strategies to
bear on overcoming conceptual and tech-
nical barriers to progress. Networks can
play a particularly powerful and influential
role in providing the core leadership,
legitimacy, and momentum needed to
establish a new scientific field.
Timing
If the time is right and the environment
ready, launching an initiative such as the
VBN is like throwing a match on dry
tinder; if it is not, even the most creative
strategy may fail to spark a fire. The time
was right for creating the Network, in
terms of recognized need and opportunity;
committed people; availability of methods,
technologies, and facilities from other
fields; and cooperative institutions.
Receptivity
Critical to the success of a new collabo-
rative venture is the receptivity of the field
Figure 1. Vector molecular biology publications in leading scientific journals from 1975 to 2006. The number of publications was
determined using a Web of Science database search for publications involving mosquitoes, ticks, sand flies, and other vectors. These two groups of
leading journals were selected: generalist (PNAS, Science, Nature, Cell, Genetics), and field-specific (Insect Molecular Biology, Insect Biochemistry &
Molecular Biology).
doi:10.1371/journal.pntd.0000343.g001
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members are from entomology and Dro-
sophila genetics fields in which collaboration
is a part of the culture. Months before VBN
members received grants awarded by the
Foundation, they began collaborating.
People
Collaboration and communication take
place between and among individuals, not
Figure 2. Vector biology grants funded by the National Institutes of Health from 1975 to 2005. The CRISP database was used to search
for grants related to mosquitoes, ticks, and other vectors (e.g., sand flies, reduviids, tsetse, etc.).
doi:10.1371/journal.pntd.0000343.g002
Figure 3. Vector biology presentations and posters at the annual meeting of the American Society of Tropical Medicine and
Hygiene from 1990 to 2005. Sessions include symposia, scientific sessions, and poster sessions specifically for vectors. Presentations include oral
presentations or posters within vector sessions. The results do not include presentations or sessions organized for specific diseases even if the disease
is vector-borne.
doi:10.1371/journal.pntd.0000343.g003
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the success of a collaborative research
endeavor are the professional and personal
attributes of the participants, and the
degree to which they meld into a collegial,
open, and productive collective. Effective
collaborators are those who: (i) have a
demonstrated commitment to interdisci-
plinary collaboration as a strategy for
overcoming substantive and technical
barriers to progress in the field; (ii) are
collegial, with excellent group process
skills, and a demonstrated capacity to
work with others; (iii) possess personal
and professional maturity and security, an
openness to new ideas and approaches,
and an ability to reach beyond current
paradigms and strategies; and (iv) are
willing to make the requisite commitment
of time and energy to listen, learn, and
make collaboration work.
Commitment to Shared Goals
The members of the VBN were, to a
person, focused intensely on doing what-
ever it took to advance the field of parasite
vector biology and, through their work
together, to strengthen the potential of
that field to produce strategies for control-
ling parasitic diseases by interrupting their
transmission by insect vectors.
Face-to-Face Interactions
The Network PLs met, on average,
three times a year. These meetings were
like lab meetings in which the PLs: (i)
trusted each other and freely presented the
results of work under way in their
laboratories; (ii) discussed barriers to
progress and how to overcome them,
collectively; and (iii) developed plans for
advancing the work of the VBN and
strengthening the field of molecular vector
biology. These meetings fostered impor-
tant personal and professional relation-
ships that continue today, as well as a
sense of shared purpose and coherent
direction.
Training
Training was integral to the VBN, not
an add-on. Each participating laboratory
trained several students and fellows, al-
most all of whom have gone on to establish
their own laboratories focused on vector
biology. Working in laboratories charac-
terized by high-quality science, open
communication, and state-of-the-art facil-
ities and technologies, trainees were im-
mersed in the collaborative ethos that was
the VBN’s hallmark. Beyond their primary
laboratory, trainees benefited from visits to
other Network laboratories, participation
in the Biology of Disease Vectors Course,
attendance at the Network institutes and
workshops, and presentations at profes-
sional conferences and symposia.
Biology of Disease Vector Course
The annual BDV course played a
critical role in building the field of
molecular vector biology around the
world. In addition, it served as an anchor
for the Network: VBN PLs designed the
Course and constituted the core faculty; a
meeting of the PLs was held during the
Course each year; all VBN trainees took
the Course early in their training experi-
ence; and the Course brought VBN
scientists and trainees into contact with
many of the current and future leaders in
the field from around the world.
Workshops
Network-sponsored workshops mobi-
lized communal expertise and experience
to tackle the critical barriers to progress in
the field. External experts who had
grappled with similar challenges in other
fields were invited to share their experi-
ences and to advise the Network on how
best to proceed. As a result, these sessions
were instrumental in the development of
strategies that were successful in overcom-
ing barriers and moving the field forward.
Flexibility
Within the boundaries of expectation
established by the Foundation, VBN
laboratories were given very wide latitude
in how they expended the grant funds
provided. As a result, Network laborato-
ries were able to spend the money in a
timely and optimal mode, directed at the
Network’s goals and without constraints of
required funder approval for trying novel
approaches (for which scientists were the
best judges).
Invisible Administration
An effective research network is one in
which administration and logistics are
effective, efficient, seamless, and invisible.
Toward this end, each Network laboratory
had an individual whose job it was to
handle the administrative aspects of the
lab’s involvement in the Network. In
addition, a single Foundation staff per-
son—the VBN Administrator—handled
overall VBN logistics and administration
and orchestrated the work of the individ-
ual lab’s administrators.
Partnering and the Power of
Leveraging
To be successful, a network must actively
engage the broader field in which it works,
openly sharing the results of its efforts and
incorporating advances achieved by others.
In this way, network resources are highly
leveraged, magnifying the impact of the
network’s funding, talent, technical capac-
ities, and discoveries.
Funders’ Opportunity
A funding agency can accomplish much
with modest resources. However, it must
choose its targets carefully, articulate
ambitious but measurable goals, recognize
the importance of timing, be strategic, be
trusting of its investigators and the dy-
namic of science, and be willing to
experiment with new funding mecha-
nisms. As a function of their indepen-
dence, foundations have a particular
opportunity to take on important but
neglected societal issues and to try flexible
new strategies for attacking them.
Summary
The VBN more than met the objectives
of The MacArthur Foundation, and it
validated the field-development concepts
that motivated its creation. Through the
separate and collaborative research and
training activities of Network laboratories,
the two-week summer course, and an
ongoing set of strategic planning and
convening activities, the VBN (i) led in
the development of proof-of-concept dem-
onstrations of genetic methods for inter-
rupting the transmission of selected para-
sitic and viral VBDs; (ii) developed and
applied the first methods for producing
transgenic mosquitoes; (iii) helped to
create the rationale, strategy, and collab-
orative approach for sequencing the ge-
nomes of the most significant mosquito
vectors of human malaria and dengue; (iv)
produced novel understanding concerning
the functions and operation of the insect
immune system, illuminated molecular
events and vulnerabilities during blood
feeding and digestion and the molecular
basis of olfaction in host-seeking; (v)
developed and offered the BDV course
and published the landmark textbook The
Biology of Disease Vectors; and (vi) trained
more than 600 students, postdoctoral
researchers, and faculty from around the
world, many of whom now fill leadership
positions in vector biology or medical
entomology; and (vii) recruited outstand-
ing scientists from other fields to vector
biology, many of whom transformed their
entire laboratories to work on vectors and
have become leaders in the field.
In conjunction with or following the
VBN initiative, other organizations initiated
or emphasized programs to target vectors
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approaches. WHO-TDR initiated a new
program on parasite vector biology empha-
sizing modern genetic and population
genetic research and training. The portfolio
of vector grants exploded at the NIH,
culminating in a Vector Biology study
section, and Gates Grand Challenge grants
and other foundation initiatives are target-
ing vectors for disease control using modern
approaches. The WHO-TDR–funded ef-
fort to incorporate scientists from the
developing world and disease-endemic
countries into Network activities has greatly
enriched the field, benefiting scientists from
both North and South, and has yielded
extraordinary collaborative studies and
efforts to control VBDs. As a result, there
is now a vibrant and productive community
of basic and applied researchers, funding
agencies, and interventionists working in
what was at the time of the Network’s
creation a seriously neglected area of public
health.
The output of the VBN in trained
people, knowledge, tools, and approaches
represents important additions to the
public health armamentarium for control
of VBDs. Indeed, new vector control
capacity combined with vaccination and
therapeutic programs provide a new
exciting and integrated opportunity to
control and perhaps regionally eradicate
some of the VBDs that are such important
causes of morbidity, mortality, and misery
in humankind.
Supporting Information
Figure S1 Participants of the Tucson,
Arizona, meeting ‘‘Prospects for Malaria
Control by Genetic Manipulation of its
Vectors,’’ held January 27–31, 1991,
sponsored by The MacArthur Foundation,
World Health Organization Special Pro-
gramme for Research and Training in
Tropical Diseases, and the University of
Arizona. Scientists with expertise in basic
molecular biology, genetics, epidemiology,
entomology, vector control, and public
health met to discuss the use and role of
molecular techniques in vector and disease
control. The official report of the meeting
was published by WHO-TDR (TDR/
BCV/MAL-ENT/91).
Found at: doi:10.1371/journal.pntd.
0000343.s001 (6.37 MB TIF)
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